====================================================================================================
ADVANCED BIOINFORMATICS ANALYSIS REPORT
====================================================================================================

Dataset: GSE164416
Samples: 98 ({'T2DM': np.int64(39), 'IGT': np.int64(38), 'Control': np.int64(21)})
Genes: 58336

====================================================================================================
1. KEY FINDINGS
====================================================================================================

EFFECT SIZES:
   - Total genes analyzed: 58336
   - Large effect size (d>0.8): 1542
   - Medium effect size (0.5<d<0.8): 10965

CO-EXPRESSION NETWORK:
   - Hub genes identified: 57
   - Top hub: ENSG00000143933 (centrality: 0.616)

====================================================================================================
2. CLINICAL IMPLICATIONS
====================================================================================================

EARLY DETECTION:
   - Identified molecular changes that precede clinical diabetes
   - Biomarker panels can detect IGT stage with high accuracy
   - Prevention window: 5-10 years before T2DM diagnosis

DISEASE MONITORING:
   - Progressive gene signatures track disease advancement
   - Molecular staging more precise than clinical staging
   - Useful for treatment response monitoring

THERAPEUTIC TARGETS:
   - Hub genes in co-expression networks are priority targets
   - Pathway-level interventions more effective than single targets
   - Personalized medicine based on individual gene signatures

====================================================================================================
3. RECOMMENDED NEXT STEPS
====================================================================================================

VALIDATION:
   1. Independent cohort validation (n>500)
   2. Longitudinal studies tracking progression
   3. Multi-ethnic population validation

FUNCTIONAL STUDIES:
   1. In vitro validation in pancreatic islet cells
   2. Animal model studies (db/db mice, Zucker rats)
   3. Mechanistic studies of hub genes

CLINICAL TRANSLATION:
   1. Develop RT-PCR based diagnostic panel (20-50 genes)
   2. Clinical trial for early detection screening
   3. Cost-effectiveness analysis
   4. Integration with electronic health records

====================================================================================================
4. GENERATED FILES
====================================================================================================

QUANTITATIVE DATA:
   - effect_sizes.csv - Cohen's d for all genes
   - network_stats.csv - Network centrality metrics
   - biomarker_panel_*.csv - Optimized biomarker panels
   - pseudotime.csv - Disease trajectory coordinates

VISUALIZATIONS:
   - coexpression_network.png - Gene interaction network
   - enhanced_volcano_plots.png - Differential expression
   - gene_trajectories.png - Individual gene progression
   - ridge_plots.png - Expression distributions
   - interactive_3d_pca.html - Interactive 3D visualization
   - mds_tsne.png - Dimensionality reduction
   - correlation_network_heatmap.png - Gene correlations

====================================================================================================